At CHX, we're focused on improving the oral health, and with it, overall health, for 125 million older adults in North America and Western Europe who suffer from poor oral health and limited access to dental care – those with Special Needs, Complex Needs or Geriatric Care needs. As a pharmaceutical company, we are alone in this important mission. If we continue to develop the Prevora platform efficiently and effectively, we hope to generate outstanding returns for our shareholders and to build an enduring pharmaceutical company by making an essential contribution to the health of under-served in our community.
CHX Technologies is a private pharmaceutical company based in Toronto. We own an Irish subsidiary, CHX Technologies Europe Ltd. The company’s core skills are in designing and conducting Phase III clinical trials, gaining first-in-class regulatory approvals and partnering with organizations on delivering more effective preventive oral health services at lower cost.